Feedback / Questions
Cimerli (ranibizumab-eqrn) - Amneal, Formycon, Coherus Oncology, Teva
https://www.formycon.com/en/blog/press-release/lucentis-biosimilar-fyb201-ranivisio-ranibizumab-approved-in-brazil/
Jun 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next